Serum Biomarkers of Iron Stores are Associated With an Increased Risk of All-Cause Mortality and 2 Cardiovascular Events in Non-Dialysis Chronic Kidney Disease Patients, With or Without Anemia

Peritoneal dialysis (PD) is an important home-based dialysis modality for treatment of end stage kidney failure, typically varying from 5% to 20% use among all dialysis patients in many countries. This educational webinar will describe case scenarios addressing 2 important areas in PD patient care and related controversies: (1) treatment of peritonitis, and (2) optimizing fluid management. Discussion will include recent PDOPPS findings in how peritonitis cure rates differ greatly by causative organism type and type of antibiotic regimen used in treating certain classes of organisms, and recent ISPD recommendations and work by Davies et al concerning fluid management in PD patients.